Feedback / Questions
AU-007 - Aulos Biosci
http://www.businesswire.com/news/home/20220223005340/en/Aulos-Bioscience-Receives-HREC-Approval-to-Initiate-First-in-Human-Clinical-Trial-Evaluating-Anti-Tumor-Activity-of-Novel-IL-2-Therapeutic-AU-007/
Feb 23, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next